Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 29,000 shares at $35.45 ($1.0M) on 2022-01-25, disclosed to the SEC on 2022-01-26.
Open-market sale of $1.0M ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.45 | 10,088 | $358K | 34.6% |
| 2 | $35.45 | 10,088 | $358K | 34.6% |
| 3 | $36.21 | 4,412 | $160K | 15.4% |
| 4 | $36.21 | 4,412 | $160K | 15.4% |
| Total | $35.68 avg | 29,000 | $1.0M | 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |